BioSpace News Archive

Syapse® announced that long-time board member and health industry veteran Frank Williams has been named as Chairman of the company’s board of directors.

Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart’s mitral position.

Medidata, a Dassault Systèmes company, announced that Labcorp, a leading global life sciences company, has selected Medidata’s technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials.

Allonnia, the bio-ingenuity company dedicated to extracting value where others see waste, today announces a North American distribution agreement with OPEC Systems, and its US subsidiary EPOC Enviro, for their SAFF Perfluoroalkyl and polyfluoroalkyl substances (PFAS) remediation technology.

Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc., headquartered in Nashville, and Tabuk Pharmaceutical Manufacturing Company, a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East, headquartered in Riyadh, Saudi Arabia, announced the launch of Cumberland’s Vibativ® injection in the Middle East.

InSitu Biologics, Inc. will share the latest investigational work on its hydrogel-lipid-microparticle matrix at the upcoming 47th Annual Regional and Acute Pain Medicine Meeting of the American Society of Regional Anesthesia in April 2022.

Human subjects now being enrolled in the second cohort of multiple ascending dose portion of the study.

Cybin Announces Initiation of Kernel Flow ® Feasibility Study Measuring Psychedelic Effects on the Brain.

Beroni Group announced that it has appointed Dr. John Chiplin as an independent director to Beroni’s Board of Directors effective April 1, 2022.

Totus Medicines, the drug discovery company harnessing proprietary chemical biology and AI to address previously untreatable cancers, announced the relocation of its headquarters to Emeryville, California.